Gael S. Roth - Publications

Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020-2025).

Journal: Chemical communications (Cambridge, England)

Published: January 22, 2026

Randomized, multicenter Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or gemcitabine in patients with resected ampullary adenocarcinoma.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 31, 2025

Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort).

Journal: JHEP reports : innovation in hepatology

Published: December 18, 2025

Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 23, 2025

Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.

Journal: Nature

Published: October 20, 2025

Ability of computed tomography and endoscopic ultrasound to predict pathological tumor node metastasis staging of resected ampullary carcinomas (ACs): an analysis of the Fédération Française de Cancérologie Digestive AC prospective cohort study.

Journal: Gastrointestinal endoscopy

Published: April 24, 2025

Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 01, 2025

TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial.

Journal: The Lancet. Oncology

Published: January 24, 2025

Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine/Tipiracil) in digestive cancers by overexpressing thymidine phosphorylase.

Journal: Cancer letters

Published: September 18, 2024

First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort.

Journal: JHEP reports : innovation in hepatology

Published: September 10, 2024

Metabolic reprogramming of hypoxic tumor-associated macrophages through CSF-1R targeting favors treatment efficiency in colorectal cancers.

Journal: Journal for immunotherapy of cancer

Published: September 09, 2024

Author Correction: Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis.

Journal: Cell discovery

Published: March 27, 2024